CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

How Far We Have Come, How Far We Have Yet to Go in Atherosclerosis Research Can Biomarkers of Myocardial Injury Provide Complementary Information to Coronary Imaging? From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events Association of Sustained Blood Pressure Control with Multimorbidity Progression Among Older Adults Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization Adenosine and adenosine receptor-mediated action in coronary microcirculation Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk: Clinical Perspectives and Basic Implications Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)

Original Research2020 May 5;141(18):1463-1476.

JOURNAL:Circulation. Article Link

Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure

JA Chirinos, L Zhao, Y Jia et al. Keywords: apolipoproteins M; heart failure; lipoproteins, HDL; sphingosine-1-phosphate; survival.

Full Text PDF